AAREY DRUGS - LongAAREY DRUGS Counter Trendline Broken + Retesting in progress.
Entry - 38-39
Target - 46.50/53.45
SL - 34.75
Study the stock & Trade Responsibly.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.27INR
46.84 MINR
3.95 BINR
About AAREY DRUGS & PHARM LTD
Sector
CEO
Mihir Rajesh Ghatalia
Headquarters
Mumbai
Website
Founded
1990
ISIN
INE198H01019
FIGI
BBG000D2FHM2
Aarey Drugs & Pharmaceuticals Ltd. engages in the trade and manufacture of pharmaceutical ingredients, drug intermediates, specialty chemicals, industrial solvents, and chemicals. Its products include mono methyl urea, dimethyl urea, theobromine, theophylline, mefanamic acid, bromomethyl, and dioxolane. The company was founded by Rajesh Pranlal Ghatalia on May 15, 1990 and is headquartered in Mumbai, India.
Buy in dips Stock 3 - Aarey DrugsBuy above 30 with the stop loss of 24. Targets are 42, 54 and 66.
Duration : One year. Note : Consult your financial advisor before investing.
watch for trendline breakout buy on breakout of trendline around 38.5 for swing trade
for swing keep sl of 34.5
Note: this is not a prediction for LONG/SHORT, trade will trigger only on given level as per technical analysis
All levels mentionedAll levels mentioned. Unnecessarily putting more words to let trading view publish
Aarey Drugs- Sign of Trend Reversal..?Accumulate
59-61
Target
65
70
75
SL below 56 CBSL
For educational purpose only, Not responsible for any financial Loss
Not SEBI registered
See all ideas
Frequently Asked Questions
The current price of AAREYDRUGS is 67.71 INR — it has increased by 0.46% in the past 24 hours. Watch AAREY DRUGS & PHARMACEUTICALS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange AAREY DRUGS & PHARMACEUTICALS stocks are traded under the ticker AAREYDRUGS.
AAREYDRUGS stock has fallen by −1.51% compared to the previous week, the month change is a 5.80% rise, over the last year AAREY DRUGS & PHARMACEUTICALS has showed a −0.22% decrease.
AAREYDRUGS reached its all-time high on Sep 5, 2024 with the price of 75.75 INR, and its all-time low was 37.00 INR and was reached on Mar 18, 2024. View more price dynamics on AAREYDRUGS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AAREYDRUGS stock is 2.80% volatile and has beta coefficient of 0.91. Track AAREY DRUGS & PHARMACEUTICALS stock price on the chart and check out the list of the most volatile stocks — is AAREY DRUGS & PHARMACEUTICALS there?
Today AAREY DRUGS & PHARMACEUTICALS has the market capitalization of 1.72 B, it has increased by 0.64% over the last week.
Yes, you can track AAREY DRUGS & PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
AAREY DRUGS & PHARMACEUTICALS is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
AAREYDRUGS net income for the last quarter is 12.39 M INR, while the quarter before that showed 21.52 M INR of net income which accounts for −42.42% change. Track more AAREY DRUGS & PHARMACEUTICALS financial stats to get the full picture.
AAREY DRUGS & PHARMACEUTICALS dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AAREY DRUGS & PHARMACEUTICALS EBITDA is 42.91 M INR, and current EBITDA margin is 2.41%. See more stats in AAREY DRUGS & PHARMACEUTICALS financial statements.
Like other stocks, AAREYDRUGS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AAREY DRUGS & PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.